THE INFLUENCE OF TUMOR IMMUNE MICROENVIRONMENT AND TUMOR IMMUNITY ON THE PATHOGENESIS, TREATMENT AND PROGNOSIS OF POST‐TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD). (12th June 2019)